ENTRAYNIA Trademark

Trademark Overview


On Monday, May 24, 2021, a trademark application was filed for ENTRAYNIA with the United States Patent and Trademark Office. The USPTO has given the ENTRAYNIA trademark a serial number of 90730515. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, October 1, 2024. This trademark is owned by Vanda Pharmaceuticals Inc.. The ENTRAYNIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of circadian rhythm diseases and disorders; Pharmaceutical preparations for the treatment of Non-24-Hour Sleep-Wake Disorder; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the reduction of cravings for alcohol, food, nicotine, opioids, or opiates; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment o...
entraynia

General Information


Serial Number90730515
Word MarkENTRAYNIA
Filing DateMonday, May 24, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of circadian rhythm diseases and disorders; Pharmaceutical preparations for the treatment of Non-24-Hour Sleep-Wake Disorder; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the reduction of cravings for alcohol, food, nicotine, opioids, or opiates; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of motion sickness; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations for the treatment of fatigue; Pharmaceutical preparations for the treatment of narcolepsy; Pharmaceutical preparations for the treatment of levodopa-induced dyskinesias in Parkinson's Disease; Pharmaceutical preparations for the treatment of viral pneumonia; Pharmaceutical preparations for the treatment of social anxiety disorder and social anxiety disorder performance-only subtype; Pharmaceutical preparations for the treatment of respiratory distress, acute respiratory distress syndrome, and inflammatory lung injury; Pharmaceutical preparations for the treatment of gastric motility and gastric emptying disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of multiple myeloma; Pharmaceutical preparations for facilitating emergence from general anesthesia; Pharmaceutical preparations for improving cognition; Pharmaceutical preparations, namely, antivirals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Trademark Events


Event DateEvent Description
Thursday, May 27, 2021NEW APPLICATION ENTERED
Thursday, August 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 4, 2022ASSIGNED TO EXAMINER
Thursday, July 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 11, 2022NON-FINAL ACTION WRITTEN
Friday, February 11, 2022NON-FINAL ACTION E-MAILED
Friday, February 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 3, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 3, 2023SOU EXTENSION 1 FILED
Monday, April 3, 2023SOU EXTENSION 1 GRANTED
Wednesday, April 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 13, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 13, 2023SOU EXTENSION 2 FILED
Friday, October 13, 2023SOU EXTENSION 2 GRANTED
Tuesday, October 1, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024SOU EXTENSION 4 FILED
Tuesday, October 1, 2024SOU EXTENSION 4 GRANTED
Tuesday, February 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 2, 2024SOU EXTENSION 3 FILED
Friday, February 2, 2024SOU EXTENSION 3 GRANTED